Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01353131 · ClinicalTrials.gov registry record
Personalized Risk Identification and Management for Arrhythmias and Heart Failure by ECG and MRI
A clinical trial of Inpatients and Outpatients With Routine 12-lead ECG, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 162
- Enrollment target
- 1
- Study location
NCT01353131: Completed study of Inpatients and Outpatients With Routine 12-lead ECG, sponsored by Johns Hopkins University.
NCT01353131 is a study of Inpatients and Outpatients With Routine 12-lead ECG that has completed, run by Johns Hopkins University. The registered enrollment target is 162 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01353131, a study of Inpatients and Outpatients With Routine 12-lead ECG, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 162 participants
- Enrollment target
- 1
- Study location
Study Summary
Prevention of myocardial functional deterioration and sudden cardiac death among individuals of intermediate risk remains one of the most elusive frontiers of contemporary medicine. While most of these individuals are known to have had contact with the medical system, they are frequently not considered to be at high risk until far advanced along one or multiple disease processes leading to irreversible myocardial loss and electric instability. The goal of this proposal is to determine the prognostic power of combining specific measures of ventricular architecture, myocardial structure and electrical function for the early identification of individuals at risk to develop ventricular arrhythmias and progressive myocardial failure leading to severe cardiovascular outcomes and death.
Conditions Studied
Study Locations (1)
Maryland
- Division of Cardiology, Johns Hopkins University School of Medicine - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 162 participants |
| Start Date | 2010-05 |
| Est. Completion | 2016-10 |
What the finished NCT01353131 record still lists
NCT01353131 is an observational study that tracks outcomes without assigning an intervention. The registered 162 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Inpatients and Outpatients With Routine 12-lead ECG appearing as the primary indexed condition, and to 0 interventions.
NCT01353131 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01353131 about?
NCT01353131 is a clinical study titled "Personalized Risk Identification and Management for Arrhythmias and Heart Failure by ECG and MRI". Prevention of myocardial functional deterioration and sudden cardiac death among individuals of intermediate risk remains one of the most elusive frontiers of contemporary medicine. While most of these individuals are known to have had contact with the medical system, they are frequently not conside...
What is the current status of trial NCT01353131?
This trial is currently completed. The enrollment target is 162 participants. The study started on 2010-05. Estimated completion is 2016-10.
What conditions does trial NCT01353131 study?
This clinical trial studies the following conditions: Inpatients and Outpatients With Routine 12-lead ECG.
Who is sponsoring clinical trial NCT01353131?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01353131 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02347111 · 162 participants · Phase 4
Pharmacogenetic Study of Antiarrhythmic Drugs for Atrial Fibrillation
- NCT02610426 · 162 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
- NCT05040711 · 162 participants · NA
mHealth Mindfulness With Patients With Serious Illness and Their Caregivers
- NCT05514717 · 162 participants · Phase 1
A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia